A detailed history of 3 Chopt Investment Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, 3 Chopt Investment Partners, LLC holds 22,313 shares of MRK stock, worth $2.07 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
22,313
Previous 34,152 34.67%
Holding current value
$2.07 Million
Previous $2.73 Billion 30.77%
% of portfolio
0.43%
Previous 0.66%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$77.6 - $87.37 $918,706 - $1.03 Million
-11,839 Reduced 34.67%
22,313 $1.89 Billion
Q2 2025

Jul 24, 2025

SELL
$73.47 - $87.12 $209,242 - $248,117
-2,848 Reduced 7.7%
34,152 $2.73 Billion
Q1 2025

Apr 24, 2025

SELL
$83.01 - $101.02 $10,874 - $13,233
-131 Reduced 0.35%
37,000 $3.35 Billion
Q4 2024

Feb 13, 2025

BUY
$96.31 - $114.76 $189,634 - $225,962
1,969 Added 5.6%
37,131 $3.72 Billion
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $71,247 - $82,669
641 Added 1.86%
35,162 $4.02 Billion
Q2 2024

Aug 21, 2024

BUY
$123.8 - $132.96 $9,780 - $10,503
79 Added 0.23%
34,521 $4.3 Billion
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $42,012 - $48,953
371 Added 1.09%
34,442 $4.57 Billion
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $58,705 - $63,885
586 Added 1.75%
34,071 $3.74 Billion
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $50,033 - $55,564
486 Added 1.47%
33,485 $3.47 Billion
Q2 2023

Jul 25, 2023

SELL
$108.61 - $118.38 $139,129 - $151,644
-1,281 Reduced 3.74%
32,999 $3.83 Billion
Q1 2023

May 22, 2023

BUY
$102.94 - $114.86 $3.53 Million - $3.94 Million
34,280 New
34,280 $3.67 Billion
Q4 2022

May 24, 2023

SELL
$87.44 - $112.11 $2,360 - $3,026
-27 Reduced 0.08%
34,253 $3.83 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track 3 Chopt Investment Partners, LLC Portfolio

Follow 3 Chopt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 3 Chopt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 3 Chopt Investment Partners, LLC with notifications on news.